Jan 31, 2023Ymmunobio Signs Transfer Ownership Agreement with Nagoya University for NPTXR antibodiesResearch indicates that NPTXR may have utility for treatment of gastro-intestinal cancers.Read more here: https://www.prnewswire.com/news-releases/ymmunobio-signs-transfer-ownership-agreement-with-nagoya-university-for-nptxr-antibodies-301733781.html
Research indicates that NPTXR may have utility for treatment of gastro-intestinal cancers.Read more here: https://www.prnewswire.com/news-releases/ymmunobio-signs-transfer-ownership-agreement-with-nagoya-university-for-nptxr-antibodies-301733781.html
Comments